• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接触蛋白-1 在帕金森病患者脑脊液中减少,并存在于路易小体中。

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson's Disease Patients and Is Present within Lewy Bodies.

机构信息

Neurochemistry Laboratory, Clinical Chemistry Department, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, 1105 AZ Amsterdam, The Netherlands.

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, 1105 AZ Amsterdam, The Netherlands.

出版信息

Biomolecules. 2020 Aug 12;10(8):1177. doi: 10.3390/biom10081177.

DOI:10.3390/biom10081177
PMID:32806791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7463939/
Abstract

Synaptic degeneration is an early phenomenon in Parkinson's disease (PD) pathogenesis. We aimed to investigate whether levels of synaptic proteins contactin-1 and contactin-2 in cerebrospinal fluid (CSF) of PD patients are reduced compared to dementia with Lewy bodies (DLB) patients and controls and to evaluate their relationship with α-synuclein aggregation. Contactin-1 and -2 were measured in CSF from PD patients ( 58), DLB patients ( 72) and age-matched controls ( 90). Contactin concentration differences between diagnostic groups were assessed by general linear models adjusted for age and sex. Contactin immunoreactivity was characterized in postmortem substantia nigra, hippocampus and entorhinal cortex tissue of PD patients ( 4) and controls ( 4), and its relation to α-syn aggregation was evaluated using confocal laser scanning microscopy. Contactin-1 levels were lower in PD patients (42 (36-49) pg/mL) compared to controls (52 (44-58) pg/mL, 0.003) and DLB patients (56 (46-67) pg/mL, 0.001). Contactin-2 levels were similar across all diagnostic groups. Within the PD patient group, contactin-1 correlated with t-α-syn, tTau and pTau ( 0.30-0.50, 0.05), whereas contactin-2 only correlated with t-α-syn ( 0.34, 0.03). Contactin-1 and -2 were observed within nigral and cortical Lewy bodies and clustered within bulgy Lewy neurites in PD brains. A decrease in CSF contactin-1 may reflect synaptic degeneration underlying Lewy body pathology in PD.

摘要

突触退化是帕金森病 (PD) 发病机制中的早期现象。我们旨在研究 PD 患者脑脊液 (CSF) 中的突触蛋白神经联络蛋白-1 和神经联络蛋白-2 水平是否低于路易体痴呆 (DLB) 患者和对照组,并评估它们与α-突触核蛋白聚集的关系。测量了 58 名 PD 患者、72 名 DLB 患者和 90 名年龄匹配的对照组的 CSF 中的接触蛋白-1 和-2。通过调整年龄和性别后的一般线性模型评估诊断组之间的接触蛋白浓度差异。在 PD 患者 (4 例) 和对照组 (4 例) 的黑质、海马和内嗅皮质组织中对接触蛋白免疫反应性进行了特征描述,并使用共聚焦激光扫描显微镜评估了其与α-突触核蛋白聚集的关系。与对照组 (52(44-58)pg/mL, 0.003)和 DLB 患者 (56(46-67)pg/mL, 0.001)相比,PD 患者的接触蛋白-1 水平较低 (42(36-49)pg/mL)。接触蛋白-2 水平在所有诊断组中相似。在 PD 患者组中,接触蛋白-1 与 t-α-突触核蛋白、tTau 和 pTau 呈正相关 (0.30-0.50, 0.05),而接触蛋白-2 仅与 t-α-突触核蛋白呈正相关 (0.34, 0.03)。在 PD 大脑中,观察到接触蛋白-1 和-2 存在于黑质和皮质路易体中,并聚集在路易氏神经突的隆起处。CSF 中接触蛋白-1 的减少可能反映了 PD 路易体病理学中突触退化的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53c3/7463939/c7654ce2865e/biomolecules-10-01177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53c3/7463939/93a2f300bcd3/biomolecules-10-01177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53c3/7463939/90fe6b72250f/biomolecules-10-01177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53c3/7463939/c7654ce2865e/biomolecules-10-01177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53c3/7463939/93a2f300bcd3/biomolecules-10-01177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53c3/7463939/90fe6b72250f/biomolecules-10-01177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53c3/7463939/c7654ce2865e/biomolecules-10-01177-g003.jpg

相似文献

1
Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson's Disease Patients and Is Present within Lewy Bodies.接触蛋白-1 在帕金森病患者脑脊液中减少,并存在于路易小体中。
Biomolecules. 2020 Aug 12;10(8):1177. doi: 10.3390/biom10081177.
2
The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.脑脊液 α-突触核蛋白和 tau/α-突触核蛋白比值对具有路易体病理的神经退行性疾病的诊断价值。
Eur J Neurol. 2020 Jan;27(1):43-50. doi: 10.1111/ene.14032. Epub 2019 Jul 24.
3
Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.帕金森病、路易体痴呆或其他神经退行性疾病患者的脑脊液中α-突触核蛋白、淀粉样β、tau、磷酸化 tau 和神经元特异性烯醇化酶水平:与认知和核医学成像结果的关系。
Neurosci Lett. 2020 Jan 10;715:134564. doi: 10.1016/j.neulet.2019.134564. Epub 2019 Nov 13.
4
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
5
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.脑脊液脂肪酸结合蛋白 3、α-突触核蛋白与阿尔茨海默病核心生物标志物在路易体疾病和阿尔茨海默病痴呆中的差异作用。
Alzheimers Res Ther. 2017 Jul 28;9(1):52. doi: 10.1186/s13195-017-0276-4.
6
TIGAR inclusion pathology is specific for Lewy body diseases.TIGAR 包涵体病理学是路易体病的特征。
Brain Res. 2019 Mar 1;1706:218-223. doi: 10.1016/j.brainres.2018.09.032. Epub 2018 Sep 26.
7
High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.外周和 CSF 生物标志物在路易体疾病中有较高的鉴别能力。
J Neural Transm (Vienna). 2020 Mar;127(3):311-322. doi: 10.1007/s00702-019-02137-2. Epub 2020 Jan 7.
8
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.帕金森病患者脑脊液中α-突触核蛋白和tau 浓度:一项队列研究。
Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X.
9
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.帕金森病和路易体痴呆患者脑脊液来源外泌体诱导α-突触核蛋白聚集体形成
Brain. 2016 Feb;139(Pt 2):481-94. doi: 10.1093/brain/awv346. Epub 2015 Dec 8.
10
Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.帕金森病和皮质路易体病中的黑质和皮质路易小体以及营养不良性黑质神经突含有α-突触核蛋白免疫反应性。
J Neuropathol Exp Neurol. 1998 Apr;57(4):334-7. doi: 10.1097/00005072-199804000-00005.

引用本文的文献

1
Inferring disease progression stages in single-cell transcriptomics using a weakly supervised deep learning approach.使用弱监督深度学习方法推断单细胞转录组学中的疾病进展阶段。
Genome Res. 2025 Jan 22;35(1):135-146. doi: 10.1101/gr.278812.123.
2
Contactin proteins in cerebrospinal fluid show different alterations in dementias.脑脊液中的联系蛋白在痴呆症中表现出不同的改变。
J Neurol. 2024 Dec;271(12):7516-7524. doi: 10.1007/s00415-024-12694-6. Epub 2024 Sep 25.
3
Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.

本文引用的文献

1
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.路易体病理存在于帕金森病中,由挤在一起的细胞器和脂膜组成。
Nat Neurosci. 2019 Jul;22(7):1099-1109. doi: 10.1038/s41593-019-0423-2. Epub 2019 Jun 24.
2
Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.脑脊液中的Contactin-1和Contactin-2作为多发性硬化症轴突区域功能障碍的潜在生物标志物。
Mult Scler J Exp Transl Clin. 2018 Dec 24;4(4):2055217318819535. doi: 10.1177/2055217318819535. eCollection 2018 Oct-Dec.
3
The Emerging Evidence of the Parkinson Pandemic.
区域间突触退化的差异与帕金森病和路易体痴呆症中α-突触核蛋白负担和轴突损伤有关。
Acta Neuropathol Commun. 2024 Jan 3;12(1):4. doi: 10.1186/s40478-023-01711-w.
4
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物?
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
5
SWATH Mass Spectrometry-Based CSF Proteome Profile of -Linked Parkinson's Disease Patients.基于 SWATH 质谱的 - 连接型帕金森病患者脑脊液蛋白质组特征分析。
Int J Mol Sci. 2022 Nov 16;23(22):14166. doi: 10.3390/ijms232214166.
6
HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target.高迁移率族蛋白B1在神经系统疾病中的作用:一种常见的生物标志物和潜在的治疗靶点。
Front Neurol. 2022 Oct 31;13:1029891. doi: 10.3389/fneur.2022.1029891. eCollection 2022.
7
Structural insights into the contactin 1 - neurofascin 155 adhesion complex.神经细胞黏附分子 1-神经束蛋白 155 黏附复合物的结构解析
Nat Commun. 2022 Nov 3;13(1):6607. doi: 10.1038/s41467-022-34302-9.
8
Fluid markers of synapse degeneration in synucleinopathies.突触核蛋白病中突触退化的液体标志物。
J Neural Transm (Vienna). 2022 Feb;129(2):187-206. doi: 10.1007/s00702-022-02467-8. Epub 2022 Feb 11.
9
Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity.机器学习识别出心脏心耳中的六种基因变异和改变是帕金森病风险预测的关键因素。
Front Genet. 2022 Jan 3;12:785436. doi: 10.3389/fgene.2021.785436. eCollection 2021.
10
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.神经病理突触标志物 NPTX2 在 DLB 患者脑脊液中的水平降低与 α-突触核蛋白和 VGF 水平相关。
Cells. 2020 Dec 29;10(1):38. doi: 10.3390/cells10010038.
帕金森病大流行的新证据。
J Parkinsons Dis. 2018;8(s1):S3-S8. doi: 10.3233/JPD-181474.
4
Contactins in the central nervous system: role in health and disease.中枢神经系统中的接触蛋白:在健康与疾病中的作用
Neural Regen Res. 2019 Feb;14(2):206-216. doi: 10.4103/1673-5374.244776.
5
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.α-突触核蛋白作为路易体痴呆症潜在的脑脊液生物标志物。
Mov Disord. 2018 Nov;33(11):1724-1733. doi: 10.1002/mds.111. Epub 2018 Nov 15.
6
Movement disorder society criteria for clinically established early Parkinson's disease.运动障碍学会制定的临床明确的早期帕金森病标准。
Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.
7
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.α-突触核蛋白寡聚体诱导人 iPSC 为基础的突触核蛋白病模型中的早期轴突功能障碍。
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):7813-7818. doi: 10.1073/pnas.1713129115. Epub 2018 Jul 10.
8
Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease.神经细胞黏附分子-2,一种突触和轴索蛋白,在阿尔茨海默病患者的脑脊液和脑组织中减少。
Alzheimers Res Ther. 2018 Jun 1;10(1):52. doi: 10.1186/s13195-018-0383-x.
9
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.α-突触核蛋白:从早期突触功能障碍到神经退行性变
Front Neurol. 2018 May 4;9:295. doi: 10.3389/fneur.2018.00295. eCollection 2018.
10
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?路易体痴呆和帕金森病痴呆是同一种疾病吗?
BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.